395 related articles for article (PubMed ID: 10557625)
1. Implementation of the mutual recognition agreement between the United States and the European Community; pharmaceutical GMP's and medical devices; establishment of a public docket and FDA contact points. Food and Drug Administration, HHS. Establishment of a public docket and FDA contact points.
Fed Regist; 1999 Mar; 64(45):11376-7. PubMed ID: 10557625
[TBL] [Abstract][Full Text] [Related]
2. Mutual recognition of pharmaceutical good manufacturing practice inspection reports, medical device quality system audit reports, and certain medical device product evaluation reports between the United States and the European Community--FDA. Final rule.
Fed Regist; 1998 Nov; 63(215):60122-64. PubMed ID: 10187390
[TBL] [Abstract][Full Text] [Related]
3. Mutual Recognition of the Food and Drug Administration and European Community Member State Conformity Assessment Procedures; pharmaceutical GMP inspection reports, medical device quality system evaluation reports, and certain medical device premarket evaluation reports--FDA. Proposed rule.
Fed Regist; 1998 Apr; 63(69):17744-71. PubMed ID: 10177764
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a public docket for medical device/radiological health policy statements and operating procedure guides--FDA. Notice.
Fed Regist; 1993 Jul; 58(142):40150-1. PubMed ID: 10127710
[TBL] [Abstract][Full Text] [Related]
5. Agency information collection activities; announcement of OMB approval; medical devices: third-party review program under the U.S./EC MRA. Food and Drug Administration, HHS. Notice.
Fed Regist; 1999 Mar; 64(44):11018. PubMed ID: 10557621
[TBL] [Abstract][Full Text] [Related]
6. International Conference on Harmonisation; guidance on good manufacturing practice for active pharmaceutical ingredients; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2001 Sep; 66(186):49028-9. PubMed ID: 12358036
[TBL] [Abstract][Full Text] [Related]
7. "Guidance for Industry: For the Submission of Chemistry, Manufacturing and Controls and Establishment Description Information for Human Blood and Blood Components Intended for Transfusion or for Further Manufacture and for the Completion of the Form FDA 356h, 'Application to Market a New Drug, Biologic or an Antibiotic Drug for Human Use;'" availability. Food and Drug Administration, HHS. Notice.
Fed Regist; 1999 May; 64(89):25049-50. PubMed ID: 10558535
[TBL] [Abstract][Full Text] [Related]
8. Agreed minutes; meeting between the Food and Drug Administration and the Health Authorities of Switzerland. Food and Drug Administration, HHS. Notice.
Fed Regist; 1999 Jun; 64(107):30038-40. PubMed ID: 10558562
[TBL] [Abstract][Full Text] [Related]
9. The history and contemporary challenges of the US Food and Drug Administration.
Borchers AT; Hagie F; Keen CL; Gershwin ME
Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
[TBL] [Abstract][Full Text] [Related]
10. "Guidance for industry: content and format of chemistry, manufacturing and controls information and establishment description information for a biological in vitro diagnostic product;" availability. Food and Drug Administration, HHS. Notice.
Fed Regist; 1999 Mar; 64(44):11023-4. PubMed ID: 10557623
[TBL] [Abstract][Full Text] [Related]
11. "Guidance for Industry: On the Content and Format of Chemistry, Manufacturing and Controls Information and Establishment Description Information for an Allergenic Extract or Allergen Patch Test"; availability. Food and Drug Administration, HHS. Notice.
Fed Regist; 1999 Apr; 64(78):20006-7. PubMed ID: 10558479
[TBL] [Abstract][Full Text] [Related]
12. Medical devices; refurbishers, rebuilders, reconditioners, servicers, and "as is" remarketers of medical devices; review and revision of compliance policy guides and regulatory requirements; request for comments and information--FDA. Advance notice of proposed rulemaking.
Fed Regist; 1997 Dec; 62(246):67011-3. PubMed ID: 10179309
[TBL] [Abstract][Full Text] [Related]
13. Draft guidance for industry; exports and imports under the FDA Export Reform and Enhancement Act of 1996--FDA. Notice.
Fed Regist; 1998 Jun; 63(113):32219-34. PubMed ID: 10180275
[TBL] [Abstract][Full Text] [Related]
14. Medical devices containing materials derived from animal sources (except for in vitro diagnostic devices), guidance for FDA reviewers and industry; availability--FDA. Notice.
Fed Regist; 1998 Nov; 63(215):60009-10. PubMed ID: 10187389
[TBL] [Abstract][Full Text] [Related]
15. International Conference on Harmonisation; Guidance on Q8 Pharmaceutical Development; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2006 May; 71(98):29344-5. PubMed ID: 16749216
[TBL] [Abstract][Full Text] [Related]
16. The Investigators' Brochure: a comparison of the draft international conference on harmonisation guideline with current Food and Drug Administration requirements.
Cocchetto DM
Qual Assur; 1995 Dec; 4(4):240-6. PubMed ID: 8890349
[TBL] [Abstract][Full Text] [Related]
17. International Conference on Harmonisation; guidance on electronic common technical document specification; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2003 Apr; 68(63):16060-1. PubMed ID: 12674113
[TBL] [Abstract][Full Text] [Related]
18. FDA implementation of standards developed by the International Conference on Harmonisation.
Booth PM
Food Drug Law J; 1997; 52(2):203-23. PubMed ID: 10557561
[No Abstract] [Full Text] [Related]
19. Medical devices; exemption from premarket notification and reserved devices; class I. Food and Drug Administration, HHS. Final rule.
Fed Regist; 2000 Jan; 65(10):2296-323. PubMed ID: 11010655
[TBL] [Abstract][Full Text] [Related]
20. Guidance of FDA's expectations of medical device manufacturers concerning the year 2000 date problem--FDA. Notice.
Fed Regist; 1998 Jun; 63(121):34433-42. PubMed ID: 10180297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
